Paragonimus IgM ELISA Kit

The Paragonimus IgM ELISA Kit is a semi-quantitative enzyme-linked immunosorbent assay (ELISA) designed for detecting IgM antibodies specific to Paragonimus species in human serum or plasma samples. This kit is intended for early diagnosis of paragonimiasis and is to be used by trained medical technologists.

Paragonimus is a parasitic lung fluke that infects humans and animals through consumption of raw or undercooked crab or crayfish. It is prevalent in Southeast Asia, Africa, and Central/South America, with sporadic cases reported in the United States linked to eating raw crayfish during river rafting trips. Once ingested, the larvae migrate through the body and settle primarily in the lungs, maturing into adult flukes within 6-10 weeks. Severe cases involve migration to the central nervous system, causing symptoms like meningitis.

Early symptoms include diarrhea and abdominal pain, followed by fever, chest pain, and fatigue. Coughing typically begins as dry and progresses to rusty-colored or blood-tinged sputum, mimicking tuberculosis symptoms. This kit uses Paragonimus antigens coated on microplates to detect IgM antibodies, enabling reliable diagnosis of acute infections. Results can be read visually or with an ELISA reader.

Paragonimus IgM ELISA Kit

√  Early Detection: Identifies acute infections through IgM antibody detection.

√  High Sensitivity: Detects low concentrations of IgM antibodies for early diagnosis.

√  High Specificity: Optimized antigen design minimizes cross-reactivity.

√  Rapid Workflow: Efficient process for quick results.

√  Clear Readout: Strong colorimetric response for easy visual or instrumental interpretation.

√  Stable Storage: Reagents remain stable at 2-8°C.

√  Quality Assurance: Includes positive and negative controls for validation.

√  Global Applicability: Compliant with international diagnostic standards for various settings.

Paragonimus IgM ELISA Kit

√  Clinical Laboratories: Early screening and diagnosis of paragonimiasis.

√  Public Health Centers: Epidemiological studies and screenings in endemic regions.

√  Parasitology Research Institutions: Supporting studies on paragonimiasis immunology and pathology.

√  Food Safety and Aquatic Agencies: Monitoring risks of foodborne parasite infections from freshwater species.

√  Remote Healthcare Facilities: Providing accessible diagnostic tools in resource-limited regions.

√  International Quarantine Services: Screening travelers and workers from endemic regions.

√  Community Health Programs: Disease prevention and control measures in high-risk areas.

√  Tourism and Travel Medicine Centers: Managing health risks for travelers consuming freshwater crabs and crayfish.